RUVBL1 and non-small cell lung carcinoma: The Kaplan–Meier survival curves revealed that OS was significantly worse in NSCLC patients with high vs. low RUVBL1 protein expression (median OS of 484 and 1676 days, respectively; HR = 2.25, 95%CI 1.17–4.32; p = 0.015; Table 3; Fig. 3a).